Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apollo Endosurgery Inc (NQ: APEN )

3.920 -0.060 (-1.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 162,255
Open 4.060
Bid (Size) 3.340 (1)
Ask (Size) 3.920 (3)
Prev. Close 3.980
Today's Range 3.580 - 4.060
52wk Range 3.580 - 10.39
Shares Outstanding 28,702,968
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week
AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,... 
From Apollo Endosurgery, Inc.
Via AccessWire
This Analyst Thinks Apollo Endosurgery's Valuation 'Does Not Assign Full Value' - Read Why
 
Via Benzinga

Performance

YTD
-55.30%
-55.30%
1 Month
-32.41%
-32.41%
3 Month
-27.41%
-27.41%
6 Month
-52.83%
-52.83%
1 Year
-44.24%
-44.24%

More News

Read More
Apollo Endosurgery: Q1 Earnings Insights
Via Benzinga
Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery to Report First Quarter Results on May 3, 2022
From Apollo Endosurgery, Inc.
Via AccessWire
Earnings Scheduled For February 22, 2022
Via Benzinga
Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors
From Apollo Endosurgery, Inc.
Via AccessWire
68 Biggest Movers From Yesterday
Via Benzinga
Apollo Endosurgery to Participate in the Cowen Healthcare Conference
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery's Return On Capital Employed Insights
Via Benzinga
Recap: Apollo Endosurgery Q4 Earnings
Via Benzinga
Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery to Present at Four Upcoming Investor Conferences
From Apollo Endosurgery, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
Via Benzinga
Recap: Apollo Endosurgery Q3 Earnings
Via Benzinga
Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET
From Apollo Endosurgery, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Product Safety
Apollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking System
From Apollo Endosurgery, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Product Safety
Apollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021
From Apollo Endosurgery, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Earnings Scheduled For November 1, 2021
Via Benzinga
Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares
From Apollo Endosurgery, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.